GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD 13D and 13G filings for Revance Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-23 7:17 pm Sale |
2024-09-30 | 13G | Revance Therapeutics, Inc. RVNC |
GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 0 0.000% |
-5,825,881 (Position Closed) |
Filing |
| 2024-02-09 10:05 am Purchase |
2023-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 5,825,881 6.630% |
332,916 (+6.06%) |
Filing |
| 2023-02-09 2:10 pm Purchase |
2022-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 5,492,965 6.680% |
1,316,885 (+31.53%) |
Filing |
| 2022-02-08 5:07 pm Purchase |
2021-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 4,176,080 5.820% |
345,129 (+9.01%) |
Filing |
| 2021-02-12 4:32 pm Purchase |
2020-12-31 | 13G | Revance Therapeutics, Inc. RVNC |
GOVERNMENT OF SINGAPORE INVESTMENT CORP PTE LTD | 3,830,951 5.760% |
865,400 (+29.18%) |
Filing |